SC
AMED

Scotia Capital’s Amedisys AMED Stock Holding History

Scotia Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,814
Closed -$292K – 679
2015
Q4 		$292K Hold
7,814
– – 0.01% 674
2015
Q3 		$297K Buy
+7,814
New +$330K 0.01% 650
2015
Q1 		– Sell
-16,920
Closed -$497K – 607
2014
Q4 		$497K Sell
16,920
-759
-4% -$18.7K 0.01% 416
2014
Q3 		$357K Buy
+17,679
New +$341K 0.01% 470

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Scotia Capital's AMED Position: Q1 2016 in Review

Scotia Capital sold out of Amedisys (AMED) in Q1 2016, closing a stake of 7,814 shares — an estimated $292K sold.

Scotia Capital first reported a position in AMED in Q3 2014 and held it in 4 quarters. The position peaked at $497K in Q4 2014. 169 funds tracked by Wall St. Rank hold AMED as of Q1 2016.

  • Scotia Capital reported no remaining Amedisys position as of Q1 2016 after selling out during the quarter.
  • Scotia Capital sold 7,814 Amedisys shares in Q1 2016, an estimated $292K.
  • Scotia Capital first reported a position in Amedisys in Q3 2014 and held it in 4 quarters.
  • Scotia Capital's Amedisys position peaked at $497K in Q4 2014.
  • 169 funds tracked by Wall St. Rank held Amedisys as of Q1 2016.

Based on Scotia Capital's 13F filing for Q1 2016, filed 12 May 2016.